[Federal Register: May 29, 2003 (Volume 68, Number 103)]
[Notices]               
[Page 32055-32056]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29my03-93]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30DAY-42-03]

 
Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 498-1210. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Clinician's Management Approach to Children with Pharyngitis--New--
National Center for Infectious Diseases (NCID), Centers for Disease 
control and Prevention (CDC). The purpose of this study is to determine 
factors associated with appropriate management of children with 
pharyngitis. We will characterize office laboratory methods currently 
used by clinicians to diagnose pharyngitis caused by group A 
streptococcus (GAS), including rapid antigen detection test (RADT) and 
throat cultures, and also assess clinicians' treatment approaches for 
pharyngitis.
    The specific goals for this study on children with pharyngitis are:
    1. To evaluate current diagnostic methods and treatment approaches 
for children with pharyngitis by primary care practitioners 
(pediatricians and family practitioners).
    2. To identify factors associated with the use of appropriate 
laboratory methods by primary care practitioners.
    3. To assess the treatment regimen including antimicrobial choices, 
length and goals of therapy.
    4. To determine the impact of full implementation of CLIA on the 
performance of these tests in office settings.
    The investigators will send out an eight-page questionnaire to a 
sample of 1000 members in each, the American Academy of Pediatrics and 
the American Academy of Family Practitioners. The survey includes 
questions on demographics; diagnostic approaches (including types of 
RADTs and cultures used); logistics in using the diagnostics (such as 
level of training of the personnel performing the tests, nature of 
quality control); clinicians' perception and understanding of the 
RADTs, including published sensitivity and specificity figures; and 
impact of CLIA (such as any change on the use of RADTs and culture). 
One month after the first mailing, each individual will be sent a 
second mailing to maximize the opportunity to complete the survey.
    The study population consists of primary care physicians from 
pediatrics and family practice. These physicians will be from all areas 
of the United States and, therefore, from diverse geographic locations. 
The total burden is estimated to be approximately 400 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                     No. of        Avg. burden/
                         Respondents                                No. of         responses/      response (in
                                                                 respondents       respondent         hours)
----------------------------------------------------------------------------------------------------------------
Physicians...................................................           2,000                1             12/60
----------------------------------------------------------------------------------------------------------------



[[Page 32056]]

Thomas A. Bartenfeld,
Acting Deputy Director for Policy, Planning and Evaluation, Centers for 
Disease Control and Prevention.
[FR Doc. 03-13373 Filed 5-28-03; 8:45 am]

BILLING CODE 4163-18-P